Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Scientific Reports|February 15, 2025
Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modelingWenli Dong, Takeo Fujii, Jing Ning, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2015
Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysisNorihiro Yamaguchi, Takeo Fujii, Shunsuke Aoi, et al.
Breast Cancer Research and Treatment|July 29, 2020
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancerSudpreeda Chainitikun, James P Long, Ruben Rodriguez-Bautista, et al.
Breast Cancer Research and Treatment|August 18, 2016
Impact of clinical trial on survival outcomesFanny Le Du, Takeo Fujii, Minjeong Park, et al.
International Journal of Medical Sciences|April 15, 2016
Functional Role of HSP47 in the Periodontal Ligament Subjected to Occlusal Overload in MiceHiroaki Mimura, Tatsuo Takaya, Saeka Matsuda, et al.
Journal of Biomedical Optics|March 6, 2024
Non-invasive blood glucose estimation method based on the phase delay between oxy- and deoxyhemoglobin using visible and near-infrared spectroscopyTomoya Nakazawa, Rui Sekine, Masato Kitabayashi, et al.
International Journal of Medical Sciences|July 17, 2015
Cytological Kinetics of Periodontal Ligament in an Experimental Occlusal Trauma ModelTatsuo Takaya, Hiroaki Mimura, Saeka Matsuda, et al.
Biochemical and Biophysical Research Communications|May 28, 2003
DNA microarray analysis of human gingival fibroblasts from healthy and inflammatory gingival tissuesPao-Li Wang, Kiyoshi Ohura, Takeo Fujii, et al.
Anticancer Research|January 1, 2015
Differential impact of fosaprepitant on infusion site adverse events between cisplatin- and anthracycline-based chemotherapy regimensTakeo Fujii, Naoki Nishimura, Kevin Y Urayama, et al.
Cancers|March 13, 2025
Efficiency of Fulvestrant Monotherapy After CDK4/6 Inhibitor Exposure: Is This a Viable Choice?Nanae Ogata, Brian G Barnett, Nicholas J H Sharp, et al.
Pageof 7